ONE in ten women suffer agonising pain from endometriosis but it is still a largely unknown condition. It causes cells from ...
It is the first allogeneic cell therapy to receive both FDA designations for the treatment of the disease ... which is being tested for Meniere’s disease, a rare inner ear condition that can affect ...
Federally funded research at Johns Hopkins offers new avenues for detecting brain disease long before it strikes ...
Sebastien Beauzile lived with the chronic pain of sickle cell anemia. Now, thanks to a groundbreaking genetic treatment, he ...
Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...
A young man from Laurelton is the first New Yorker with sickle cell disease to receive Lyfgenia, a life-changing gene therapy treatment that has wiped away the debilitating illness, The Post first ...
He’s got new blood. A Long Island hospital said it administered life-changing Lyfgenia gene therapy treatment and successfully wiped away sickle cell disease from a Laurelton man. Cohen Children ...
Researchers are working overtime to develop therapies that, for the first time, specifically target Guillain-Barré Syndrome. That's welcome news.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback